European Shorting
To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director | 2013-01-30 | Buy | 5,700,000 | $0.66 | 3762 | -9.09 | 0.00 | 0.00 | 92.6262 |  Link |
| ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director | 2013-01-25 | Buy | 1,762,000 | $0.65 | 1145.3 | -7.69 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director | 2012-06-29 | Sell | 1,283,300 | $0.73 | 936.8 | -17.81 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | HENNEY CHRISTOPHER S | Director | 2012-06-29 | Buy | 200,000 | $0.75 | 150 | -20 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO (Click for the stocks that their CEOs have bought) | 2012-06-29 | Buy | 20,000 | $0.76 | 15.2 | -21.05 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director | 2012-03-22 | Sell | 1,548,500 | $2.48 | 3840.3 | -75.81 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ODINK DEBRA | Chief Technology Officer | 2012-03-01 | Sell | 2,000 | $6.57 | 13.1 | -90.87 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and C.E.O. | 2012-02-15 | Sell | 15,000 | $7.84 | 117.6 | -92.35 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | Hislop Colin | Chief Medical Officer | 2012-02-03 | Sell | 30,000 | $8.2 | 246 | -92.68 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ODINK DEBRA | Chief Technology Officer | 2012-02-01 | Sell | 2,000 | $7.67 | 15.3 | -92.18 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 2012-02-01 | Sell | 15,000 | $7.66 | 114.9 | -92.17 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and Chief Executive | 2012-01-17 | Sell | 15,000 | $6.75 | 101.3 | -91.11 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ODINK DEBRA | Chief Technology Officer | 2012-01-06 | Sell | 1,200 | $6.5 | 7.8 | -90.77 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | SOFINNOVA VENTURE PARTNERS VI | 10% Owner | 2011-12-30 | Sell | 25,000 | $6.23 | 155.8 | -90.37 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | HEALY JAMES | Director, 10% Owner | 2011-12-30 | Sell | 25,000 | $6.23 | 155.8 | -90.37 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | SOFINNOVA VENTURE PARTNERS VI | 10% Owner | 2011-12-22 | Sell | 50,000 | $6.37 | 318.5 | -90.58 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | HEALY JAMES | Director, 10% Owner | 2011-12-22 | Sell | 50,000 | $6.37 | 318.5 | -90.58 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO | 2011-12-15 | Sell | 15,000 | $6.34 | 95.1 | -90.54 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director | 2011-12-13 | Sell | 56,200 | $6.68 | 375.4 | -91.02 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director, 10% Owner | 2011-11-18 | Sell | 52,000 | $6.76 | 351.5 | -91.12 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO | 2011-11-15 | Sell | 30,000 | $6.96 | 208.8 | -91.38 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | ORBIMED ADVISORS LLC | Director, 10% Owner | 2011-11-15 | Sell | 60,000 | $6.95 | 417 | -91.37 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | Hislop Colin | Chief Medical Officer | 2011-11-08 | Sell | 15,000 | $6.74 | 101.1 | -91.1 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO | 2011-10-21 | Sell | 23,235 | $6.25 | 145.2 | -90.4 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO | 2011-10-18 | Sell | 6,745 | $6.25 | 42.2 | -90.4 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | LOWE CHRISTOPHER P. | CFO & CBO | 2011-08-02 | Sell | 5,000 | $7.31 | 36.6 | -91.79 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO | 2011-07-15 | Sell | 15,000 | $7.95 | 119.3 | -92.45 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | VANTAGEPOINT VENTURE ASSOCIATE | 10% Owner | 2011-06-16 | Sell | 3,100 | $8.67 | 26.9 | -93.08 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | TRUEX PAUL F | President and CEO | 2011-06-15 | Sell | 15,000 | $8.3 | 124.5 | -92.77 | 0.00 | 0.00 | 92.6262 | Link |
| ANTH | Anthera Pharmac... | VANTAGEPOINT VENTURE ASSOCIATE | 10% Owner | 2011-06-14 | Sell | 1,999 | $8.8 | 17.6 | -93.18 | 0.00 | 0.00 | 92.6262 | Link |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Louis Moore Bacon | 2013-03-31 | 2,000,000 | 0.02% | New Buy | |
 Most recent portfolio changes are included for Premium Members only!
| |||||
Feedback
My Portfolios
Browse Gurus
Insider Trade Rss Update
Bookmark
This page has been successfully added into your 
RSS
Add Notes, Comments or Ask Questions
Comments